Dr. Nicholas Elias Rose, MD

Dr. Rose practices at P. James Voloshin M.D., Inc in Newport Beach, California.

Dr. Rose's NPI, 1174550784, was assigned on June 27, 2006. Dr. Rose graduated from David Geffen School of Medicine at UCLA in 1991. Dr. Rose holds California license G74766.

Dr. Rose's primary practice is P. James Voloshin M.D., Inc, at 360 San Miguel Dr, Newport Beach, CA 92660 in Orange County. The practice phone is (949) 759-0995.

Dr. Rose's primary practice is P. James Voloshin M.D., Inc in Newport Beach, California. Dr. Rose is also affiliated with Hoag Hospital Newport Beach. The medical group on file is Orthopaedic Specialty Institute. Dmand AI also links Dr. Rose to 2 more group practices and clinics, 2 medical groups, 1 physician office and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rose practices, 5 sites in all. Vendor and product names are available with a free account.

Hand surgery is Dr. Rose's primary specialty in the NPI Registry, under taxonomy code 207XS0106X. Dr. Rose is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Rose's licenses on file in 2 states: California and Texas.

Dmand AI lists arm, wrist, hand fracture and dislocation, carpal tunnel syndrome, enthesopathy in arms, hand joint or tendon inflammation, joint cyst and minor injury to a limb among the conditions Dr. Rose treats.

CMS data shows 5,709 Medicare services from Dr. Rose across 29 procedure codes in 2024, for 770 Medicare patients. Medicare paid $240,204 for them.

CMS counts 770 Medicare patients who saw Dr. Rose in 2024. The largest group is 65 to 74, with 386 patients. 75% of them have arthritis, and 75% have high cholesterol. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rose's median patient age at 68, with 56% women.

In 2024, Dr. Rose wrote 117 Medicare Part D claims for 98 patients. 100% of them were for generic drugs. CMS names the drug for 88 of them, across 4 drugs with 11 or more claims each, at $449 in total drug cost. In 2023, CMS named 119 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Rose for performance year 2024, reported individually. Dr. Rose accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 60 procedures of upper limb (arm) arthroscopy (minimally invasive joint repair) by Dr. Rose, more than 90% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Rose. The most frequent topics are Pain Measurement. Dr. Rose's most frequent co-authors are Scott Kevin Forman, MD and Lawrence Allen Feiwell, MD.

CMS Open Payments shows 13 general payments to Dr. Rose from 10 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. ExsoMed Corporation paid the most, $92.

Dmand AI lists 1 award for Dr. Rose.

Dr. Rose graduated from David Geffen School of Medicine at UCLA in 1991. Dr. Rose is a member of AAOS, ACS and ASSH.

Dr. Rose is in network with 13 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.